What Is CBA/CEA, and Why Are They Doing This to Us?

Publisher Website
Google Scholar
Abstract
Many physicians approach cost-benefit and cost-effectiveness analysis (CBA/CEA) with something akin to what Sir James Frazer described as "the awe and dread with which the untutored savage contemplates his mother-in-law." 1 This is unwise and unnecessary. The recently published report of the Office of Technology Assessment2 makes it clear that CBA/CEA is neither a purgative nor a panacea nor a placebo. This well-written, carefully documented study explains the strengths and weaknesses of CBA/CEA, reviews attempts to apply it in health care, and offers a set of policy options and recommendations for future action. The report deserves the attention of physicians and . . .
Keywords

This publication has 1 reference indexed in Scilit: